Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma

Autor: Willemijn Theelen, O Krijgsman, K Monkhorst, T Kuilman, DDGC Peters, S Cornelissen, M Ligtenberg, SM Willems, JLG Blaauwgeers, CJM van Noesel, DS Peeper, MM van den Heuvel, K Schulze

The authors have removed this preprint from Research Square.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3ac60376d516046774498019db5601cb
https://doi.org/10.21203/rs.3.rs-26299/v1

Large-scale GWAS identifies multiple loci for hand grip strength providing biological insights into muscular fitness

Autor: Sm, Willems, Dj, Wright, Fr, Day, Trajanoska K, Pk, Joshi, Ja, Morris, Am, Matteini, Fc, Garton, Grarup N, Oskolkov N, Thalamuthu A, Mangino M, Liu J, Ra, Scott

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::85295fe5e470f91ce4219eb26653d7e4
http://europepmc.org/abstract/PMC/PMC5510175

Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy.

Autor: de Jager VD; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Plomp P; Department of Respiratory Medicine, Isala Hospital, Zwolle, the Netherlands., Paats MS; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., van Helvert S; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Elst AT; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., van den Berg A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Dubbink HJ; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., van Geffen WH; Department of Pulmonary Diseases, Medical Center Leeuwarden, Leeuwarden, the Netherlands., Zhang L; Structural Biology in Drug Design, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands., Hendriks LEL; Department of Pulmonary Diseases, GROW - School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands., Hiltermann TJN; Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Hiddinga BI; Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Hijmering-Kappelle LBM; Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Jalving M; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Kluiver J; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Koopman B; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., van Kruchten M; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., van der Logt EMJ; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Molecular Diagnostics, Pathology Friesland, Leeuwarden, the Netherlands., Piet B; Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands., van Putten J; Department of Pulmonary Diseases, Martini Hospital, Groningen, the Netherlands., Reitsma BH; Department of Pulmonology, Nij Smellinghe, Drachten, the Netherlands., Rutgers SR; Department of Pulmonology, Treant Hospital Group, Scheper Hospital, Emmen, the Netherlands., de Vries M; Department of Pulmonology, Tjongerschans, Heerenveen, the Netherlands., Stigt JA; Department of Respiratory Medicine, Isala Hospital, Zwolle, the Netherlands., Groves MR; Structural Biology in Drug Design, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands., Timens W; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Willems SM; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., van Kempen LC; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Schuuring E; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: e.schuuring@umcg.nl., van der Wekken AJ; Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: a.j.van.der.wekken@umcg.nl.

Publikováno v: ESMO open [ESMO Open] 2024 Nov; Vol. 9 (11), pp. 103966. Date of Electronic Publication: 2024 Nov 04.

Optimising primary molecular profiling in non-small cell lung cancer.

Autor: Schouten RD; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Schouten I; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Schuurbiers MMF; Department of Pulmonology, Radboud University Medical Centre, Nijmegen, The Netherlands., van der Noort V; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Damhuis RAM; Integraal Kankercentrum Nederland (IKNL), Utrecht, The Netherlands., van der Heijden EHFM; Department of Pulmonology, Radboud University Medical Centre, Nijmegen, The Netherlands., Burgers JA; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Barlo NP; Pulmonology, Noordwest Ziekenhuis Groep, Alkmaar, The Netherlands., van Lindert ASR; Department of Pulmonology, University Medical Centre Utrecht, Utrecht, The Netherlands., Maas KW; Department of Pulmonology, Haaglanden Medical Centre, The Hague, The Netherlands., van den Brand JJG; Department of Pulmonology, Meander Medical Centre, Amersfoort, The Netherlands., Smit AAJ; Department of Pulmonology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands., van Haarst JMW; Department of Pulmonology, Tergooi Ziekenhuizen, Hilversum, The Netherlands., van der Maat B; Department of Pulmonology, Flevoziekenhuis, Almere, The Netherlands., Schuuring E; Department of Pathology, University Medical Centre Groningen, Groningen, The Netherlands., Blaauwgeers H; Department of Pathology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands., Willems SM; Department of Pathology, University Medical Centre Groningen, Groningen, The Netherlands.; Department of Pathology, University Medical Centre Utrecht, Utrecht, The Netherlands., Monkhorst K; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van den Broek D; Department of Clinical Chemistry, Netherlands Cancer Institute, Amsterdam, The Netherlands., van den Heuvel MM; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pulmonology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Publikováno v: PloS one [PLoS One] 2024 Jul 31; Vol. 19 (7), pp. e0290939. Date of Electronic Publication: 2024 Jul 31 (Print Publication: 2024).

Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands.

Autor: de Jager VD; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Cajiao Garcia BN; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kuijpers CCHJ; The Dutch Nationwide Pathology Databank (Palga), Houten, the Netherlands., de Bock GH; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Maas WJ; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Timens W; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., van Kempen LC; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Department of Pathology, University Hospital Antwerp, University of Antwerp, Edegem, Belgium., van der Wekken AJ; Department of Pulmonary Diseases and Tuberculosis, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Schuuring E; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Willems SM; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: s.m.willems@umcg.nl.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Jul; Vol. 205, pp. 114125. Date of Electronic Publication: 2024 May 20.